Cargando…

Current perspective on rituximab in rheumatic diseases

The steadily increasing knowledge regarding pathogenetic mechanisms in autoimmune rheumatic diseases has paved the way to different therapeutic approaches. In particular, the market entry of biologics has dramatically modified the natural history of rheumatic chronic inflammatory diseases with a mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schioppo, Tommaso, Ingegnoli, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633295/ https://www.ncbi.nlm.nih.gov/pubmed/29042750 http://dx.doi.org/10.2147/DDDT.S139248

Ejemplares similares

The role of extracellular vesicles in rheumatoid arthritis: a systematic review
por: Schioppo, Tommaso, et al.
Publicado: (2021)

Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview
por: Gualtierotti, Roberta, et al.
Publicado: (2018)

Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon
por: Ingegnoli, Francesca, et al.
Publicado: (2015)

A Posteriori Dietary Patterns and Rheumatoid Arthritis Disease Activity: A Beneficial Role of Vegetable and Animal Unsaturated Fatty Acids
por: Edefonti, Valeria, et al.
Publicado: (2020)

Current Perspectives on Contemporary Rheumatic Mitral Valve Repair
por: Dejsupa, Chaninda, et al.
Publicado: (2021)

Potential Short-Term Air Pollution Effects on Rheumatoid Arthritis Activity in Metropolitan Areas in the North of Italy: A Cross-Sectional Study
por: Ingegnoli, Francesca, et al.
Publicado: (2021)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
por: Moog, Philipp, et al.
Publicado: (2015)

Does Pizza Consumption Favor an Improved Disease Activity in Rheumatoid Arthritis?
por: De Vito, Roberta, et al.
Publicado: (2023)

Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event
por: Berger, Joseph R., et al.
Publicado: (2018)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Current status of rheumatic heart disease in India
por: Negi, P.C., et al.
Publicado: (2019)

Current treatment of hepatitis C-associated rheumatic diseases
por: Ferri, Clodoveo, et al.
Publicado: (2012)

Perspectives on epigenetic-based immune intervention for rheumatic diseases
por: Gray, Steven G
Publicado: (2013)

Rheumatic heart disease screening: Current concepts and challenges
por: Dougherty, Scott, et al.
Publicado: (2017)

Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective
por: Hajar, Rachel
Publicado: (2016)

Off-label use of rituximab in refractory pediatric rheumatic diseases: a single-center experience
por: Aguiar, Francisca, et al.
Publicado: (2014)

Rituximab-Related Late-Onset Neutropenia in Patients with Rheumatic Diseases: Successful Re-Challenge of the Treatment
por: Reitblat, Tatiana, et al.
Publicado: (2015)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
por: Wade, Stefanie D., et al.
Publicado: (2021)

Erratum in: Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective
Publicado: (2017)

P.0493 COVID-19 related perceived stress in patients with rheumatic diseases: an Italian cross-sectional study
por: Posio, C., et al.
Publicado: (2021)

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
por: Supronik, Jakub, et al.
Publicado: (2022)

COVID-19 related poor mental health and sleep disorders in rheumatic patients: a citizen science project
por: Ingegnoli, Francesca, et al.
Publicado: (2021)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
por: Rodríguez, Sandra, et al.
Publicado: (2020)

The Rheumatic Diseases
Publicado: (1950)

The Rheumatic Diseases
Publicado: (1945)

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
por: Avouac, Jérôme, et al.
Publicado: (2021)

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)

The Rheumatic Diseases
Publicado: (1905)

The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease
por: Seckeler, Michael D, et al.
Publicado: (2011)

Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum
por: Rwebembera, Joselyn, et al.
Publicado: (2022)

Osteoimmunology in rheumatic diseases
por: Schett, Georg
Publicado: (2009)

Genetics of rheumatic disease
por: Clarke, Alex, et al.
Publicado: (2009)

The macrophages in rheumatic diseases
por: Laria, Antonella, et al.
Publicado: (2016)

Radiosynovectomy in rheumatic diseases
por: Ćwikła, Jarosław B., et al.
Publicado: (2014)

Arthritis and the Rheumatic Diseases
Publicado: (1952)

Diseases of the Joints and Rheumatism
Publicado: (1948)

Textbook of the Rheumatic Diseases
Publicado: (1951)

Osteoporosis in Rheumatic Diseases
por: Adami, Giovanni, et al.
Publicado: (2019)

Rituximab in kidney disease and transplant
por: Chauhan, Kajal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n60u969fb3iedev0utkt5qb3v6